Literature DB >> 677369

Histoplasmosis in Belize, Central America.

F Quinones, J P Koplan, L Pike, F Staine, L Ajello.   

Abstract

After two small outbreaks of histoplasmosis in Belize, an epidemiologic survey was carried out. Forty percent of 141 persons in two groups tested demonstrated a positive histoplasmin reaction. In one study group there was a significant association between visiting caves and histoplasmin positivity. Histoplasma capsulatum was not isolated in 20 soil specimens collected from outbreak-associated caves, but was isolated from 1 of 26 bats collected from the same caves. The presence of histoplasmosis in Belize, C.A. is documented, and this disease should be considered in differential diagnosis in patients, both residents and visitors in Belize, with compatible clinical presentations.

Entities:  

Mesh:

Year:  1978        PMID: 677369     DOI: 10.4269/ajtmh.1978.27.558

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Epidemiologic skin test survey of sensitivity to paracoccidioidin, histoplasmin and sporotrichin among gold mine workers of Morro Velho Mining, Brazil.

Authors:  M T Rodrigues; M A de Resende
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

Review 2.  Tropical respiratory medicine. 3. Histoplasmosis and pulmonary involvement in the tropics.

Authors:  S Houston
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

Review 3.  Infections associated with adventure travel: A systematic review.

Authors:  Nathan D Gundacker; Robert J Rolfe; J Martin Rodriguez
Journal:  Travel Med Infect Dis       Date:  2017-03-27       Impact factor: 6.211

Review 4.  Re-drawing the Maps for Endemic Mycoses.

Authors:  Nida Ashraf; Ryan C Kubat; Victoria Poplin; Antoine A Adenis; David W Denning; Laura Wright; Orion McCotter; Ilan S Schwartz; Brendan R Jackson; Tom Chiller; Nathan C Bahr
Journal:  Mycopathologia       Date:  2020-02-10       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.